Adaptive Biotechnologies Corp (NASDAQ:ADPT) price closed lower on Monday, March 25, dropping -3.70% below its previous close.
A look at the daily price movement shows that the last close reads $3.24. The company’s 5Y monthly beta was ticking 1.27. Taking into account the 52-week price action we note that the stock hit a 52-week high of $9.08 and 52-week low of $2.61. The stock subtracted -22.77% on its value in the past month.
Adaptive Biotechnologies Corp, which has a market valuation of $452.68 million, is expected to release its quarterly earnings report May 01, 2024 – May 06, 2024. Analysts tracking ADPT have forecast the quarterly EPS to shrink by -0.35 per share this quarter, while the same analysts predict the annual EPS to hit -$1.31 for the year 2024 and up to -$1.06 for 2025. In this case, analysts estimate an annual EPS growth of 16.00% for the year and 19.10% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $38.21 million, with the likely lows of $34.8 million and highs of $40 million. The average estimate suggests sales growth for the quarter will likely rise by 1.50% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $175.61 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow 3.10% above that which the company brought in 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ADPT a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that ADPT’s price is at present -14.38% off the SMA20 and -18.42% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 34.88, with weekly volatility standing at 6.88%. The indicator jumps to 7.08% when calculated based on the past 30 days. Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s beta value is holding at 1.25, while the average true range (ATR) indicator is currently reading 0.25.
An analysis of the Adaptive Biotechnologies Corp (NASDAQ:ADPT) stock in terms of its daily trading volume indicates that the 3-month average is 1.44 million.
Current records show that the company has 145.08M in outstanding shares. The insiders’ percentage holdings are 4.54% of outstanding shares while the percentage share held by institutions stands at 95.41%. But the -36.33% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
